Enlivex Therapeutics Ltd. logo
Enlivex Therapeutics Ltd. ENLV
$ 1.25 5.81%

Annual report 2023
added 12-21-2024

report update icon

Enlivex Therapeutics Ltd. ROCE Ratio 2011-2024 | ENLV

Annual ROCE Ratio Enlivex Therapeutics Ltd.

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-95.53 -42.27 -21.33 -27.19 -74.43 -53.5 -25.56 -564.63 -85.97 -23.08 - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-21.33 -564.63 -101.35

Quarterly ROCE Ratio Enlivex Therapeutics Ltd.

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
- - -4.2 -8.41 -8.41 -4.2 -11.54 -14.68 -14.68 -7.34 -7.34 - - - - - - - - - -109.4 -218.79 -218.79 -109.4 -136.35 -53.9 -53.9 -26.95 -26.95 - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
-4.2 -218.79 -57.51